Bin S. Yang
Impact in
-
- Regulation of Appetite and Obesity
-
- Diabetes Treatment and Management
Papers in
-
- Regulation of Appetite and Obesity 10
-
- Diabetes Treatment and Management 8
- Co-authors
- Brian Finan (10 shared papers)Richard D. DiMarchi (7 shared papers)Diego Pérez–Tilve (5 shared papers)Matthias H. Tschoep (5 shared papers)Vasily M. Gelfanov (4 shared papers)Piotr A. Mroz (1 shared paper)Dongxiang Liu (2 shared papers)Ziwei Huang (2 shared papers)
- Journals
- Molecular Metabolism (5 papers)Nature Metabolism (4 papers)Cell Metabolism (3 papers)Journal of Clinical Investigation (2 papers)Nature Medicine (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Bin S. Yang
29 papers receiving 2.6k citations
Bin S. Yang's Hit Papers
Peers
Comparison fields: 5 of 84
- Endocrine and Autonomic Systems 574
- Endocrinology, Diabetes and Metabolism 1k
- Pharmacology 338
- Surgery 343
- Physiology 192
Countries citing papers authored by Bin S. Yang
This map shows the geographic impact of Bin S. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin S. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin S. Yang more than expected).
Fields of papers citing papers by Bin S. Yang
This network shows the impact of papers produced by Bin S. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin S. Yang. The network helps show where Bin S. Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin S. Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans Hit paper breakdown → | 2013 | 599 |
| 2 | A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents Hit paper breakdown → | 2014 | 549 |
| 3 | 2012 | 265 | |
| 4 | 2018 | 195 | |
| 5 | 2016 | 168 | |
| 6 | 2020 | 119 | |
| 7 | 2014 | 114 | |
| 8 | The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets Hit paper breakdown → | 2023 | 91 |
| 9 | 2015 | 88 | |
| 10 | 2023 | 78 | |
| 11 | 2017 | 76 | |
| 12 | 2022 | 44 | |
| 13 | 2015 | 39 | |
| 14 | 2004 | 37 | |
| 15 | 2024 | 29 | |
| 16 | 2022 | 28 | |
| 17 | 2019 | 21 | |
| 18 | 2022 | 20 | |
| 19 | 2021 | 18 | |
| 20 | 2022 | 17 |
About Bin S. Yang
Bin S. Yang is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology and Molecular Biology, having authored 29 papers that have together received 2.6k indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (10 papers), Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (7 papers), Chemical Synthesis and Analysis (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Cellular transport and secretion (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (574 citations), Endocrinology, Diabetes and Metabolism (1k citations), Pharmacology (338 citations), Surgery (343 citations) and Physiology (192 citations). Bin S. Yang has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Brian Finan, Richard D. DiMarchi, Diego Pérez–Tilve, Matthias H. Tschoep, Vasily M. Gelfanov, Piotr A. Mroz, Dongxiang Liu, Ziwei Huang, Jonathan D. Douros and Franck Mauvais‐Jarvis. Their work appears in journals such as Molecular Metabolism, Nature Metabolism, Cell Metabolism, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.